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ORIGINAL ARTICLE

Genotoxicity of Anti–Tumor Necrosis Factor
Therapy in Patients With Juvenile
Idiopathic Arthritis
ERKAN DEMIRKAYA,1 ISMET COK,2 EMRE DURMAZ,2 ONUR K. ULUTAS,2 NURAY AKTAY AYAZ,1
NESRIN BESBAS,1 AND SEZA ÖZEN1

Objective. To assess the possible effects of both inﬂammation and the anti–tumor necrosis factor agents (anti-TNF) on
DNA damage with a speciﬁc assay, and their effects on the repair capacity of DNA.
Methods. From a group of 20 children with juvenile idiopathic arthritis (JIA), 16 patients who completed the study and
16 control subjects were evaluated. DNA damage and repair capacity were analyzed by the comet assay at the level of
peripheral lymphocytes before anti-TNF (etanercept) injections and on the 15th, 90th, and 180th days after the ﬁrst
injection.
Results. The amount of damage as detected by the aforementioned assay was higher in patients with JIA compared with
controls. On the 15th day after the initial anti-TNF injection, there was a decrease in the mean DNA tail length of JIA
patients, however on the 90th day an increase was observed; thereafter, an upward trend was observed until the end of
the study. JIA patients had a DNA repair capacity that was signiﬁcantly less than that of controls.
Conclusion. The results of the comet technique suggests that JIA patients already have increased basal DNA damage
before anti-TNF therapy; they are more sensitive to the DNA damage produced by H2O2, and have a less efﬁcient DNA
repair system in comparison with control cells. After an initial improvement at 2 weeks, parameters of genotoxicity
worsened, and DNA repair was further impaired 6 months after the addition of an anti-TNF agent to treatment.

INTRODUCTION
Anti–tumor necrosis factor (anti-TNF) therapy has become
a cornerstone in the treatment of juvenile idiopathic arthritis (JIA) and has dramatically changed the disease
course. Anti-TNF agents have an overall good safety proﬁle in patients with rheumatoid arthritis (RA), psoriatic
arthritis, ankylosing spondylitis, Crohn’s disease psoriasis, and JIA (1). However, with increasing use, cases of
malignancy have been reported, especially in adults with
RA (2). Since RA itself has been associated with increased
malignancy, it has been hard to clarify the exact role of
anti-TNF treatment in these cases. The rheumatology literature also lacks studies on possible mechanisms.
The comet assay or single-cell gel test is a microgel

electrophoresis technique that measures DNA damage at
the level of single cells. (3). The comet assay is attractive to
many researchers for many reasons, and it is a valuable
tool for investigating fundamental aspects of DNA damage
and cellular responses to this damage (4). The assay has
been used in fundamental research for DNA damage and
repair, in genotoxicity testing of novel chemicals and pharmaceuticals, environmental biomonitoring, and human
population monitoring (3). The aim of this study was to
investigate the DNA damage and repair capacity using the
comet assay in patients with JIA before and after receiving
anti-TNF therapy.
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Subjects and sampling. This study was performed at
Hacettepe University Medical School, Department of Pediatrics and Gazi University Pharmacy Faculty, Department of Toxicology. During the enrollment period, a total
of 20 children diagnosed with JIA according to Durban
criteria and who still had active disease despite receiving
6 months of methotrexate (MTX; 15 mg/m2/week) were
included. All had polyarticular-onset or systemic-onset
disease with a polyarticular disease course. Sample 0 rep73
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resented the sample obtained after 6 months of MTX treatment (i.e., just before the start of anti-TNF treatment [etanercept; 0.8 mg/kg/week]). Samples 15, 90, and 180 were
obtained 15, 90, and 180 days after the start of anti-TNF
treatment, respectively. The enrolled patients were not
exposed to any genotoxic agents such as radiation, chemicals, or indoor smoking. All patients were receiving concomitant nonsteroidal antiinﬂammatory drugs (NSAIDs)
and no patient was receiving continuous oral corticosteroid treatment during the study period. The control group
consisted of 16 healthy age-and sex-matched subjects with
no known exposure to genotoxic agents. None of the patients and the controls or their ﬁrst degree relatives had
any known genetic disease.
Venous blood samples (3 ml) were collected in heparinized glass tubes. Samples were taken just before each biologic therapy session (day 0), on the 15th, 90th, and 180th
days. Only 1 blood sample was drawn from the control
group.
Chemicals and media. Frosted microscope slides were
obtained from Menzel (Braunschweig, Germany) and all
plastics were from Corning Laboratory Sciences (Corning,
New York, NY), with the exception of microtubes, which
were purchased from Treff Lab (Degersheim, Switzerland).
All chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) with the exception of RPMI 1640 medium, fetal calf serum (FCS), phytohemagglutinin (PHA),
and trypan blue, which were obtained from Biochrom
(Berlin, Germany).
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were then washed 3 times (for 5 minutes each), with Tris
buffer (0.4 M Tris, pH 7.5), at 4°C before staining them
with 65 l ethidium bromide (20 g/ml). Each analysis
was done in duplicate and carried out immediately after
sample collection without freezing or storing. Cell viability, using trypan blue, was found to be ⬍95% at each time
point of the study. Repair capacity was deﬁned as the
relative decrease of the DNA migration length (tail length)
60 minutes after hydrogen peroxide treatment (7).
Image analysis of the slides. After the staining process,
100 cells were analyzed using double slides that were
selected randomly for examination at ⫻200 magniﬁcation
under a ﬂuorescent microscope (Zeiss-Axioskop, Oberkochen, Germany) equipped with an excitation ﬁlter 515–
560 nm and a 100 WHg lamp. DNA migration (tail length),
tail intensity, and tail moments were measured, using
Comet Assay III image analysis system (Perceptive Instruments, Suffolk, UK) (Figure 1). All slides were coded and
scored blindly.
Statistical analysis. Statistical analysis was performed
using SPSS version 15.0 (SPSS, Chicago, IL). Data were
expressed as mean, median, minimum and maximum values, percentages, and SDs. Mann-Whitney U test, Friedman’s test, and Wilcoxon’s signed rank test were used to
compare data between or within groups. P values ⬍ 0.05
were considered signiﬁcant.

RESULTS
Single-cell gel electrophoresis. The lymphocytes were
isolated with Histopaque 1077 in phosphate buffered saline (PBS) on ice from heparinized blood samples. The
lymphocyte suspension was then divided into 2 identical
groups; group 1 was used to measure repair capacity via
H2O2 exposure, and group 2 was used for regular singlecell gel electrophoresis. The procedure was carried out as
follows: lymphocytes suspended in ice-cold PBS were exposed to 100 M H2O2 for 5 minutes on ice in microcentrifuge tubes (⬃2 ⫻ 105 cells/ml). To examine repair of
H2O2 damage in lymphocytes, cells were resuspended in
RPMI 1640, supplemented with 20% FCS, 2 mM L-glutamine and incubated at 37°C for 1 hour (5). The single-cell
gel electrophoresis assay was performed under alkaline
conditions using an adaptation of the method as described
previously by Singh et al (6). The lymphocytes were mixed
with 100 l of 0.65% low-melting-point agarose in PBS at
37°C and rapidly pipetted onto a frosted glass microscope
slide precoated with 100 ml of 1% agarose, spread out
with a coverslip, and maintained at 4°C for 30 minutes to
solidify.
After removal of the coverslip, the slides were immersed
in lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM
Tris, NaOH to pH 10.0, and 1% Triton X-100) for overnight
at 4°C, to remove cellular proteins. Slides were initially
placed in an electrophoresis tank containing 1 mM
Na2EDTA and 300 mM NaOH, (pH 13) for 20 minutes.
Afterward, the tank was set at 25 V (1.6 V/cm, 300 mA) for
20 minutes at an ambient temperature of 4°C. The slides

Four of the 20 children enrolled did not complete the
study; 1 child with a diagnosis of systemic-onset JIA died
due to macrophage activation syndrome and 3 patients
stopped anti-TNF therapy and did not complete the study.
Therefore, 16 patients (8 girls and 8 boys) completed the
study. The control group also consisted of 8 girls and 8
boys. The age of the patients and the controls was mean ⫾
SD 11.11 ⫾ 4.29 years (range 3–18 years) and 11.32 ⫾ 3.96
years (range 4 –18 years), respectively (P ⬎ 0.05). There
were no statistically signiﬁcant differences between the
height and weight values of the children (P ⬎ 0.05).
When mean ⫾ SD baseline values were compared, JIA
patients were found to have increased DNA damage as
compared with the healthy controls (36.46 ⫾ 7.88 versus
30.31 ⫾ 1.83; P ⫽ 0.029). Comparison of the mean DNA
tail length of JIA patients on the 0th, 15th, 90th, and 180th
days after the initiation of anti-TNF injections are shown
in Table 1. The amount of damage was higher in the JIA
population when compared with controls on all studied
dates (P ⬍ 0.05). On the 15th day after anti-TNF injection,
there was a decrease in the mean ⫾ SD DNA tail length of
the patients from 36.46 ⫾ 7.88 (day 0, baseline level) to
35.79 ⫾ 5.56. On the 90th day, the median tail length again
began to increase, after which it had an upward trend till
the end of the study (Figure 2).
Patients with JIA at baseline were found to have decreased DNA repair (mean SD 41.95 ⫾ 11.79 versus
49.73 ⫾ 5.63; P ⫽ 0.037) as compared with healthy controls. Comparison of the mean DNA repair of JIA patients
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Figure 1. A comet assay image of a human lymphocyte obtained after in vitro challenge
with H2O2 from patients with juvenile rheumatoid arthritis exposed to etancerept taken with
the Comet Assay II image analysis system (Perceptive Instruments, Suffolk, UK). The tail
length (m) of cells were analyzed at baseline, after in vitro challenge with H2O2, and after
1 hour repair.

on the 0th, 15th, 90th, and 180th days after the initiation of
anti-TNF injections are shown in Table 2. On the 15th day
of anti-TNF treatment, there was no signiﬁcant difference
as compared with baseline (Day 0); however the difference
became signiﬁcant on the 90th day and thereafter (Figure
3).

DISCUSSION
This is the ﬁrst study assessing the DNA damage/genotoxicity and DNA repair mechanisms in children with JIA
who received anti-TNF treatment. We have demonstrated
that cells of JIA patients have increased basal DNA damage, are more sensitive to the DNA damage produced by
H2O2, and have less efﬁcient DNA repair system in comparison with control cells. Parameters of genotoxicity were

also found to be worsened and DNA repair was further
impaired 6 months after the addition of an anti-TNF agent
to MTX therapy.
Biologic effects of DNA-damaging agents have been detected by the use of a number of techniques. Singh et al (6)
developed a simple approach, the comet assay, for sensitive detection of DNA damage as well as the assessment of
DNA repair in individual cells. Single-cell gel electrophoresis has proven to be a very sensitive method to assess
DNA damage induced by several agents, and to assess
individual cell repair kinetics (8). To assess the DNA re-

Table 1. Mean DNA tail length values (m) of patients
with JIA during treatment*
Anti-TNF therapy
duration, days
0–15
0–90
0–180
15–90
15–180
90–180

DNA tail length,
mean ⴞ SD

P†

(36.46 ⫾ 7.88) – (35.79 ⫾ 5.56)
(36.46 ⫾ 7.88) – (40.19 ⫾ 5.73)
(36.46 ⫾ 7.88) – (42.49 ⫾ 7.73)
(35.79 ⫾ 5.56) – (40.19 ⫾ 5.73)
(35.79 ⫾ 5.56) – (42.49 ⫾ 7.73)
(40.19 ⫾ 5.73) – (42.49 ⫾ 7.73)

1.0
1.0
0.47
0.08
0.02
0.36

* JIA ⫽ juvenile idiopathic arthritis; TNF ⫽ tumor necrosis factor.
† By Wilcoxon’s signed rank test with Bonferroni corrections.

Figure 2. Median DNA tail length values (m) of the control
patients and the patients with juvenile idiopathic arthritis during
treatment. Anti-TNF ⫽ anti–tumor necrosis factor.
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Table 2. Mean DNA repair capacity values of patients
with JIA during treatment (%)
Anti-TNF therapy
duration, days
0–15
0–90
0–180
15–90
15–180
90–180

DNA repair capacity,
mean ⴞ SD

P†

(41.95 ⫾ 11.79) – (47.33 ⫾ 8.17)
(41.95 ⫾ 11.79) – (38.19 ⫾ 7.41)
(41.95 ⫾ 11.79) – (38.78 ⫾ 6.05)
(47.33 ⫾ 8.17) – (38.19 ⫾ 7.41)
(47.33 ⫾ 8.17) – (38.78 ⫾ 6.05)
(38.19 ⫾ 7.41) – (38.78 ⫾ 6.05)

0.30
1.00
1.00
0.03
0.04
1

* JIA ⫽ juvenile idiopathic arthritis; TNF ⫽ tumor necrosis factor.
† By Wilcoxon’s signed rank test with Bonferroni corrections.

pair capacity of cells from our study groups, DNA damage
was induced with 100 M H2O2, which caused high DNA
damage level without signiﬁcant cell mortality. H2O2 can
penetrate the cell membrane easily and initiate the generation of highly reactive species through the transition
metal catalyzed Haber-Weiss reaction (5).
The DNA damage in our cells should be properly repaired before DNA replication and cell division, in order
to prevent the critical mutations and susceptibility to
chronic diseases and cancer. The risk of cancer introduced
with the use of anti-TNF drugs is controversial. An increase in lymphoma and solid cancers has been reported
in RA patients receiving anti-TNF treatment (9). However,
RA itself is also associated with an increased risk of lymphoma as outlined above. Thus, we thought that studying
DNA damage would reﬂect a certain aspect of the possible
association of the disease and treatment on the risk of
malignancy.
The comet assay has been used for screening mutagen
sensitivity and DNA repair capacity in human peripheral
lymphocytes (10). In a study performed by Andresson et
al, there was a correlation between the sensitivity to the
DNA damaging effect of H2O2 and the DNA repair capacity
in human lymphocytes (11). In our study, the sensitivity of

the lymphocytes to the damaging effect of H2O2 was higher
in the JIA patients as compared with controls. It may be
speculated that inﬂammation is effective in this impairment. In fact Ramos-Remus et al have assessed genotoxicity in their RA patients through a “micronuclei assay” (12).
They have shown that with this method genotoxicity was
increased in RA. They showed no difference among patients that used methotrexate and thus suggested that the
increased micronuclei, reﬂecting genotoxicity was associated with the disease itself and not with the use of MTX
(12).
There is evidence for increased oxidative stress in RA
(13). In turn, the reactive oxygen molecules produced by
an activated oxidative stress have the potential to damage
the nucleic acids and DNA. Altindag et al have shown
increased DNA damage in their RA cohort and suggested
that the DNA damage they observed was primarily due to
this oxidative stress (14). Oxidative stress also impairs the
DNA repair mechanisms. The products of oxidative stress
are cytotoxic and mutagenic. In fact, somatic mutations of
p53, a tumor suppressor gene, have been shown in the
synovium of RA patients (15). TNF␣ enhances the damaging effects of reactive oxygen species. It has been suggested
that increased free radicals may contribute to the cancer
risk, and oxidized DNA bases have been associated with
malignancy (16). In addition, increased inﬂammation per
se may also be associated with this risk through the activation of reactive oxygen species (ROS) or directly through
the inﬂammatory cytokines (14). These facts may explain
the increase of DNA damage in JIA patients when compared with controls. Furthermore, this may explain the
initial improvement of the DNA damage parameters observed with anti-TNF treatment in our cohort. Anti-TNF
treatment may be expected to decrease the DNA damage
through the down regulation of the ROS and blocking of a
major inﬂammatory cytokines in these patients. In fact, the
initial improvement in the DNA repair mechanism and
decreased DNA damage observed at 2 weeks may be explained by these effects. However, the DNA damage slowly
increased in the ﬁrst 6 months along with impairment in
the DNA repair mechanism. The mechanism yet remains
obscure. On the other hand, we do not know if this effect
fades away at later time points or whether the repair mechanism is subsequently restored because of the suppression
of inﬂammation. However, we suggest that the increased
DNA damage and impaired DNA repair as compared with
the MTX treatment warrants further studies to elucidate
the signiﬁcance of these genotoxic effects and determine
whether they are long term.
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